Electromed Inc
$ 28.50
-0.80%
26 Dec - close price
- Market Cap 238,720,000 USD
- Current Price $ 28.50
- High / Low $ 29.44 / 27.34
- Stock P/E 30.32
- Book Value 5.35
- EPS 0.94
- Next Earning Report 2026-02-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.13 %
- ROE 0.19 %
- 52 Week High 35.56
- 52 Week Low 17.73
About
Electromed, Inc. (NYSE: ELMD) is a leading healthcare company focused on airway clearance therapy solutions utilizing advanced high-frequency chest wall oscillation (HFCWO) technology to improve respiratory care for a range of patients. Based in New Prague, Minnesota, Electromed serves both domestic and international markets, reflecting its dedication to enhancing patient health outcomes worldwide. With a robust product portfolio and an unyielding focus on meeting the increasing demand for effective respiratory treatments, the company is strategically positioned for sustained growth and significant impact within the healthcare sector.
Analyst Target Price
$36.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-12 | 2025-08-26 | 2025-05-05 | 2025-02-11 | 2024-11-12 | 2024-08-27 | 2024-05-07 | 2024-02-13 | 2023-11-07 | 2023-08-22 | 2023-05-09 | 2023-02-14 |
| Reported EPS | 0.25 | 0.25 | 0.21 | 0.22 | 0.16 | 0.2 | 0.17 | 0.19 | 0.02 | 0.12 | 0.12 | 0.11 |
| Estimated EPS | 0.21 | 0.22 | 0.21 | 0.18 | 0.03 | 0.14 | 0.13 | 0.1 | 0.1 | 0.13 | 0.1 | 0.04 |
| Surprise | 0.04 | 0.03 | 0 | 0.04 | 0.13 | 0.06 | 0.04 | 0.09 | -0.08 | -0.01 | 0.02 | 0.07 |
| Surprise Percentage | 19.0476% | 13.6364% | 0% | 22.2222% | 433.3333% | 42.8571% | 30.7692% | 90% | -80% | -7.6923% | 20% | 175% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-10 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.27 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ELMD
2025-12-18 22:08:57
Electromed has secured a new $10 million senior secured revolving credit facility with BMO Bank, maturing on December 16, 2026. This new agreement replaces their prior credit facility with Choice Financial Group and is expected to enhance liquidity and support various corporate needs. The facility is secured by a first-priority lien on substantially all assets and includes specific financial covenants.
2025-12-04 05:09:05
Wall Street analysts project a 36.98% upside for Electromed (ELMD) stock, with a mean price target of $36.67. This optimism is further supported by strong agreement among analysts on upward earnings estimate revisions. While price targets are not the sole factor for investment decisions, the low standard deviation and positive earnings outlook suggest potential for the stock.
2025-12-02 03:52:07
Wall Street analysts project a 36.98% upside for Electromed (ELMD), with a mean price target of $36.67 and a low standard deviation indicating strong agreement. Despite general skepticism about analysts' price targets, ELMD's positive earnings estimate revisions and a Zacks Rank #2 (Buy) suggest potential for upward movement. Investors are advised to use price targets as a starting point for further research rather than the sole basis for investment decisions.
2025-11-24 03:52:07
Electromed, Inc. (NYSE American: ELMD) announced its participation in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference, NobleCon21, on Wednesday, December 3, 2025. Jim Cunniff, Electromed's President and CEO, will present at 5:00 PM ET, with a video webcast available the following day. The company is a leader in airway clearance technologies, headquartered in New Prague, Minnesota.
2025-11-20 16:05:00
Electromed, Inc. (NYSE American: ELMD) announced its participation in NobleCon21, Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference. Jim Cunniff, Electromed's President and CEO, will present at the event on December 3, 2025, with a video webcast available on the company's website afterward. Electromed specializes in airway clearance technologies, including the SmartVest® Airway Clearance System.
2025-11-19 05:09:30
Electromed, Inc. announced its participation in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference, NobleCon21, on December 3, 2025. Jim Cunniff, President and CEO, will present at 5:00 pm ET, with a webcast available the next day. The company, known for its SmartVest® Airway Clearance System, will share insights at the event in Boca Raton, Florida.
